Search Results - "Frolova, Mona"

Can any breast skin thickening be staged as T4? by Amosova, Viktoriia A., Petrovskii, Aleksandr V., Karpova, Marina S., Ponedel’nikova, Nataliia V., Frolova, Mona A.

“…Data analysis showed that many diagnostic issues in breast cancer patients with skin involvement are not systematized. In some cases when the tumor is small…”
Get full text

Abstract P3-20-09: Surgery vs radiation therapy as the first stage treatment in patients with locally advanced breast cancer with incomplete clinical response by Petrovsky, Alexander, Amosova, Victory, Trofimova, Oxana, Frolova, Mona

“…Abstract Objective: The management of patients with locally advanced breast cancer (LABC) with skin involvement continues to be one of the most controversial…”
Get full text

REAL CLINICAL PRACTICE OF LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER TREATMENT PATTERNS WITH PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY IN RUSSIAN FEDERATION by Frolova, Mona, Karaseva, Vera, Tjulandin, Sergey

Get full text

PO59 - REAL CLINICAL PRACTICE OF LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER TREATMENT PATTERNS WITH PALBOCICLIB IN COMBINATION WITH ENDOCRINE THERAPY IN RUSSIAN FEDERATION by Frolova, Mona, Karaseva, Vera, Tjulandin, Sergey

Get full text

Abstract PS5-38: Short course of preoperative tamoxifen in premenopausal breast cancer patients: Biomarker changes and survival by Frolova, Mona, Stenina, Marina, Petrovsky, Alexander, Krohina, Olga, Tjulandin, Sergei

“…Abstract Background: Luminal HER2 negative breast cancer is a highly heterogeneous disease, which complicates the choice of optimal systemic treatment in early…”
Get full text

Abstract PO5-26-04: The value of skin involvement in achieving of pCR in patients with locally advanced breast cancer by Amosova, Viktory, Petrovskiy, Alexander, Trofimova, Oxana, Frolova, Mona, Rumyantsev, Alexey

“…Abstract Objective: The management of patients with locally advanced breast cancer (LABC) with skin involvement (edema or thickening) continues to be one of…”
Get full text

Frequency of brain metastases in patients with locally advanced triple negative breast cancer after neoadjuvant platinum-based chemotherapy: Impact of BRCA1/2 mutations by Glazkova, Elena, Stenina, Marina, Frolova, Mona A., Ignatova, Ekaterina, Rumyantsev, Alexey, Petrovsky, Alexander, Tjulandin, Sergei

“…Abstract only 1079 Background: patients with triple negative breast cancer has poor survival outcomes. Achievement of pathological complete response (pCR)…”
Get full text

Efficacy and safety of intensified platinum-based neoadjuvant chemotherapy in locally advanced triple-negative breast cancer: Preliminary results of non-randomized phase II study by Glazkova, Elena, Frolova, Mona, Stenina, Marina, Ignatova, Ekaterina, Rumyantsev, Alexey, Petrovsky, Alexander, Krohina, Olga, Tjulandin, Sergei

“…Abstract only e12116 Background: patients with locally-advanced triple negative breast cancer (TNBC) have dismal prognosis with current standard of care…”
Get full text

TREATMENT OF PATIENTS WITH LOCALLY ADVANCED BREAST CANCER WITH INCOMPLETE CLINICAL RESPONSE by Amosova, Victoriia, Trofimova, Oxana, Frolova, Mona, Karpova, Marina, Ponedelnikova, Natalia, Kasymova, Anastasia, Zagashtokova, Albina, Petrovsky, Alexander

Get full text

PO76 - TREATMENT OF PATIENTS WITH LOCALLY ADVANCED BREAST CANCER WITH INCOMPLETE CLINICAL RESPONSE by Amosova, Victoriia, Trofimova, Oxana, Frolova, Mona, Karpova, Marina, Ponedelnikova, Natalia, Kasymova, Anastasia, Zagashtokova, Albina, Petrovsky, Alexander

Get full text

Ultrasound (US) elasometry in axillary lymph node (ALN) staging for breast cancer (BC) patients by Petrovsky, Alexander, Khakurinova, Nafset, Berdnikov, Sergey, Frolova, Mona, Sholokhov, Vladimir

“…Abstract only…”
Get full text

Abstract PO4-22-09: Impact of time to surgery after neoadjuvant chemotherapy on pCR rate in locally-advanced breast cancer by Petrovskiy, Alexander, Amosova, Viktory, Trofimova, Oxana, Frolova, Mona, Soloshenko, Anastasya, Rumyantsev, Alexey

“…Abstract Objective: Neoadjuvant chemotherapy along with surgical treatment are the important parts of treatment for locally advanced breast cancer. Extending…”
Get full text

Neoadjuvant chemotherapy with dose-dense doxorubicin, cisplatin, and paclitaxel in patients with early triple-negative breast cancer (TNBC) by Frolova, Mona, Ignatova, Ekaterina, Glazkova, Elena, Petrovsky, Alexander, Tjulandin, Sergei

“…Abstract only…”
Get full text

Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer by Harbeck, Nadia, Lipatov, Oleg, Frolova, Mona, Udovitsa, Dmitry, Topuzov, Eldar, Ganea-Motan, Doina Elena, Nakov, Roumen, Singh, Pritibha, Rudy, Anita, Blackwell, Kimberly

“…This randomized, double-blind trial compared proposed biosimilar LA-EP2006 with reference pegfilgrastim in women receiving chemotherapy for breast cancer…”
Get full text

Role of different germline BRCA mutations in response to platinum-based chemotherapy in patients (pts) with triple-negative breast cancer (TNBC) by Frolova, Mona, Ignatova, Ekaterina, Stenina, Marina B., Petrovsky, Alexander, Tjulandin, Sergei

“…Abstract only…”
Get full text

Induction chemotherapy for patients with Locally advanced triple negative breast cancer by Ignatova, Ekaterina, Frolova, Mona, Stenina, Marina B., Petrovsky, Alexander, Tjulandin, Sergei

“…Abstract only…”
Get full text

Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer by Tankova, Tsvetalina, Senkus, Elżbieta, Beloyartseva, Maria, Borštnar, Simona, Catrinoiu, Doina, Frolova, Mona, Hegmane, Alinta, Janež, Andrej, Krnić, Mladen, Lengyel, Zoltan, Marcou, Yiola, Mazilu, Laura, Mrinakova, Bela, Percik, Ruth, Petrakova, Katarina, Rubovszky, Gábor, Tokar, Margarita, Vrdoljak, Eduard

“…Alpelisib is an α-selective phosphatidylinositol 3-kinase inhibitor used for treating hormone receptor-positive (HR+), human epidermal growth receptor…”
Get full text

The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low‐ and middle‐income countries and the MENA region by Elghazaly, Hesham, Aref, Adel T., Anderson, Benjamin O., Arun, Banu, Yip, Cheng‐Har, Abdelaziz, Hany, Ghosn, Marwan, Al‐Foheidi, Meteb, Cardenosa, Gilda, Leung, Jessica W. T., Gado, Nivine, Balch, Charles M., Sabry, Mohamed, Ezz Elarab, Lobna, Giuliano, Armando E., El‐Zawahry, Heba M., Abdel Karim, Khaled, Nasr, Azza, Maki, Hussein, Chung, Hannah, Saadeddin, Ahmed, Abdelwahab, Manal M., Al Tahan, Fatina M., Chalabi, Nivine, Frolova, Mona, Kamal, Rasha M., Shehata, Mohamed A., Bahie Eldin, Nermean, Elghazawy, Hagar

“…In low‐middle income countries (LMICs) and the Middle East and North Africa (MENA) region, there is an unmet need to establish and improve breast cancer (BC)…”
Get full text

Olanzapine (OLN) versus aprepitant (APR) in patients receiving high-emetogenic chemotherapy: Final results of randomized phase II trial by Rumyantsev, Alexey, Glazkova, Elena, Nasyrova, Rukhshona, Ignatova, Ekaterina, Chitia, Lia, Popova, Anna, Chekini, Dzhennet, Kochetkova, Yaroslava, Kit, Sergei, Elsnukaeva, Kheda, Menshikova, Sophia, Sekhina, Olga, Pokataev, Ilya, Tyulyandina, Alexandra, Stenina, Marina, Frolova, Mona A., Bulanov, Anatoly, Fedyanin, Mikhail, Tryakin, Alexey, Tjulandin, Sergei

“…Abstract only 11504 Background: Management of chemotherapy-induced nausea and vomiting (CINV) remains challenging. OLN might provide several benefits over APR…”
Get full text

Neoadjuvant chemotherapy with metronomic doxorubicin, cyclophosphamide, and capecitabine in patients with locally advanced (LA) triple-negative breast cancer (TNBC) by Frolova, Mona, Skrypnikova, Marina, Ignatova, Ekaterina, Petrovsky, Alexander, Stenina, Marina, Ivankina, Oxana, Vishnevskaja, Yana, Tjulandin, Sergei

“…Abstract only e12027 Background: TNBC is associated with aggressive behavior and poor prognosis. It has been shown that patients (pts) with TNBC with…”
Get full text